Recovery coaches for chronic disease management

We've been talking about talking about peer supports and recovery coaches for more than a decade. The use of para-professionals in the field goes back several decades. Now, a new study evaluates a similar role for enhancing management of other chronic diseases. Disease Management Care Blog provides a little analysis: There is increasing interest in incorporating lay-persons in the outpatient … Continue reading Recovery coaches for chronic disease management

Buprenorphine and emotional reactivity

The following article was shared with me by a reader. Not surprisingly, the emphasized portion below caught my eye. [emphasis mine] Abstract Addictions to illicit drugs are among the nation’s most critical public health and societal problems. The current opioid prescription epidemic and the need for buprenorphine/naloxone (Suboxone®; SUBX) as an opioid maintenance substance, and its … Continue reading Buprenorphine and emotional reactivity

Solving the prescription opioid problem

I've posted several times recently on the problem of opioid over-prescription and overdose. Some might assume that I want some regulatory or statutory intervention to address the issue. Truth is, I've got more questions than answers and I would not support a response that forces us to choose between treating pain and preventing addiction and … Continue reading Solving the prescription opioid problem

Less is more – Antipsychotics and Recovery from First-Episode Psychosis

A very interesting finding with profound implications for addicts who experience a psychotic episode. (Particularly since it's so difficult to tease out whether it was substance -induced.) Importance  Short-term outcome studies of antipsychotic dose-reduction/discontinuation strategies in patients with remitted first-episode psychosis (FEP) showed higher relapse rates but no other disadvantages compared with maintenance treatment; however, long-term effects … Continue reading Less is more – Antipsychotics and Recovery from First-Episode Psychosis

Not available?

Another study finds no benefit from cognitive behavioral therapy and contingency management with opiate replacement treatment. [CORRECTED: See below] Background and aims The Controlled Substances Act requires physicians in the United States to provide or refer to behavioral treatment when treating opioid-dependent individuals with buprenorphine; however no research has examined the combination of buprenorphine with … Continue reading Not available?